September S&P 500 E-Mini futures (ESU25) are trending up +0.26% this morning, attempting to snap a five-session losing streak, with focus squarely on a highly anticipated speech from Federal Reserve Chair Jerome Powell.

Below, we share with you three top-ranked large-cap blend mutual funds. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).

Big banks??? earnings surge, resilient deal activity, and favorable valuations put focus on financial ETFs like XLF, VFH, KBWB and IYF.

Healthcare stocks trade at a 30-year discount, with XLV showing signs of rebound as Buffett and hedge funds boost exposure.

These 6 stocks turned modest $1K investments into millions by mid-2025. See which companies delivered massive returns.

At the Wyoming research conference last year, Powell had promised to lower rates and support the job market when the unemployment rate started to rise, while in 2022 he underscored the Fed's inflation-fighting rigor. \\

Fed Chair Jerome Powell is due to speak Friday at 10 a.m. New York time at the Wyoming symposium. Ahead of his talk, which will be closely monitored for clues on the central bank’s monetary path, Fed Bank of Cleveland president Beth Hammack said she woul

CION, AM and KGS made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 22, 2025.

These stocks should be able to rebound strongly.

Wall Street will be focused on Fed Chair Jerome Powell’s speech Friday morning at the central bank’s annual confab in Jackson Hole, Wyoming. “Powell is in a really tough spot,” said Jon Hilsenrath, senior advisor at StoneX Group Inc. “He’ll likely acknow

CBRE, Jones Lang LaSalle and Newmark Group gain momentum as outsourcing demand and tech investments help offset real estate industry headwinds.

Ursula Marchioni, investment and portfolio solutions EMEA head at BlackRock, discusses the outlook for equities and why she favors a diversified, defensive approach in the current climate. She speaks on Bloomberg Television.

This dividend stock has a reliable payout that's a full percentage point higher than the industry average.

StoneCo, CVS Health, Integer and USANA Health Sciences stand out as low P/CF value plays with solid growth forecasts in a volatile market.

RING surged to a 52-week high, fueled by rising gold prices, Fed rate-cut hopes, and safe-haven demand.